← Back to Clinical Trials
Recruiting NCT04451473

Lung Surgery With Enhanced Recovery VS. Lung Surgery Without Enhanced Recovery

Trial Parameters

Condition Lung Cancer
Sponsor The Second Hospital of Shandong University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 350
Sex ALL
Min Age 18 Years
Max Age 85 Years
Start Date 2019-10-08
Completion 2023-06-30
Interventions
Enhanced Recovery After Surgery (ERAS )Traditional perioperative management without Enhanced Recovery After Surgery (ERAS )

Brief Summary

Objective: The adoption of Enhanced Recovery Surgery programs in lung resection is relatively recent with limited outcome data. This study aimed to determine the impact of an Enhanced Recovery Surgery pathway on short- term and long- term results in patients undergoing lung resection for primary lung cancer. Methods: A Randomized Controlled Trial was designed to collect the perioperative data on consecutive patients undergoing lung resection for primary lung cancer. Patients will be randomizely assigned to the ERAS- Group and Control- Group. Short-term and long- term effect will be compared between the two groups.

Eligibility Criteria

Inclusion Criteria: patients with stage I-IIIa Non-small-cell Lung Cancer underwent radical resection or other benign lung lesions need VATS surgery. \- Exclusion Criteria: cardio-pulmonary function couldn't tolerate surgery \-

Related Trials